What is iSpecimen Inc (ISPC) stock price today?

iSpecimen Inc (ISPC) currently trades at $5.23 per share. The stock has a market capitalization of $91280.00 and a P/E ratio of —x.

Is ISPC stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, iSpecimen Inc has a Smart Value Score of 30/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 1/9 and Altman Z-Score is -14.20.

What is iSpecimen Inc's revenue and earnings?

iSpecimen Inc has trailing twelve-month (TTM) revenue of $1.93M with profit margins of 0.00%. Earnings per share (EPS) is $-91.20.

Is iSpecimen Inc financially healthy?

iSpecimen Inc's Piotroski F-Score is 1/9 (weak financial health). The Altman Z-Score of -14.20 places it in the distress.

ISPC

iSpecimen Inc

NASDAQ: ISPC · HEALTHCARE · DIAGNOSTICS & RESEARCH

$5.23

+22.48% today

Updated 2026-04-30

Market cap

$91280.00

P/E ratio

—

P/S ratio

0.05x

EPS (TTM)

$-91.20

Dividend yield

—

52W range

$4 – $103

Volume

34.8M

Market cap

$91280.00

P/E ratio

—

P/S ratio

0.05x

EPS (TTM)

$-91.20

Dividend yield

—

52W range

$4 – $103

Volume

34.8M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

4.0

Quality

2.5

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-14.2

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$3.00

-42.64%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.09x — low leverage

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -14.20 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-916926.00

- Revenue declining -96.50% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$10.40M	$9.93M	$9.29M	$1.93M	$1.93M
Net income	$-10.25M	$-11.10M	$-12.50M	$-10.49M	$-5.00M
EPS	—	—	—	—	$-91.20
Free cash flow	$-9.01M	$-10.55M	$-8.32M	$-4.24M	$-916926.00
Profit margin	-98.50%	-111.80%	-134.51%	-543.68%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ISPC	$91280.00	30	2.7	2.5	5.0	4.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

iSpecimen Inc trades at $5.23. Our Smart Value Score of 30/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -14.20, it sits in the distress. TTM revenue stands at $1.93M.

Frequently asked questions

What is iSpecimen Inc's stock price?

iSpecimen Inc (ISPC) trades at $5.23.

Is iSpecimen Inc overvalued?

Smart Value Score 30/100 (Grade F, Strong Sell).

What is the price target of iSpecimen Inc (ISPC)?

The analyst target price is $3.00, representing -42.6% downside from the current price of $5.23.

What is iSpecimen Inc's revenue?

TTM revenue is $1.93M.

Piotroski F-Score?

1/9 — weak financial health.

Altman Z-Score?

-14.20 — distress.

Company info

SectorHEALTHCARE

IndustryDIAGNOSTICS & RESEARCH

CountryUSA

ExchangeNASDAQ

CurrencyUSD

ispecimen.com

Quick metrics

P/S ratio0.05x

ROE-327.80%

Beta1.98

50D MA$7.72

200D MA$24.68

Shares out0.00B

Float0.00B

Short ratio—

Avg volume34.8M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ISPC vs LLY →ISPC vs JNJ →ISPC vs ABBV →Stock screener →